Samsung Biologics to acquire Switzerland's PolyPeptide Group in $1.8 billion all-cash deal
South Korea's Samsung Biologics said on Monday that it had made an all-cash bid of 1.46 billion Swiss francs ($1.8 billion) for Switzerland's PolyPeptide Group.
Samsung Biologics to acquire Switzerland's PolyPeptide Group in $1.8 billion all-cash deal basliginda one cikan gelisme: South Korea's Samsung Biologics said on Monday that it had made an all-cash bid of 1.46 billion Swiss francs ($1.8 billion) for Switzerland's PolyPeptide Group.
Fonvera editor notu: Haberin piyasa etkisini izlemek icin ilgili varlik sayfalari ve ekonomik takvim akisi birlikte okunmalidir.